Vertex Pharmaceuticals Incorporated
Treating cancer with ATR inhibitors

Last updated:

Abstract:

This invention relates to methods and compositions for treating pancreatic cancer. More specifically, this invention relates to treating pancreatic cancer with certain ATR inhibitors in combination with gemcitabine and/or radiation therapy. This invention also relates to methods and compositions for treating non-small cell lung cancer. More specifically, this invention relates to treating non-small cell lung cancer with an ATR inhibitor in combination with cisplatin or carboplatin, etoposide, and ionizing radiation.

Status:
Grant
Type:

Utility

Filling date:

28 Feb 2014

Issue date:

27 Oct 2020